Moleculin Biotech
MBRX
MBRX
18 hedge funds and large institutions have $2.28M invested in Moleculin Biotech in 2020 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$278K | |
| 2 | +$198K | |
| 3 | +$55.3K | |
| 4 |
Truist Financial
Charlotte,
North Carolina
|
+$34K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$14.9K |
Top Sellers
| 1 | -$869K | |
| 2 | -$451K | |
| 3 | -$34K | |
| 4 |
HWA
HCR Wealth Advisors
Los Angeles,
California
|
-$14K |
| 5 |
Squarepoint
New York
|
-$11K |